Cargando…
Thymidylate Synthase Overexpression Drives the Invasive Phenotype in Colon Cancer Cells
Thymidylate synthase (TYMS) is the crucial enzymatic precursor for DNA biosynthesis and, therefore, the critical target for numerous types of chemotherapy, including the most frequently applied agent in colon cancer treatment 5-fluorouracil (5-FU). TYMS also seems to be associated with cancer metast...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219882/ https://www.ncbi.nlm.nih.gov/pubmed/35740289 http://dx.doi.org/10.3390/biomedicines10061267 |